We demonstrated that loss of NKAIN2 function occurs in a large proportion of prostate cancer cases, which may lead to overactivity of Na+/K+-ATPase and consequently prostate cancer development and progression. The gene discussed is NKAIN2; the disease is prostate carcinoma.